Brooks Announces $33 Million to Address Major Health Issues Facing Hoosiers
WASHINGTON, DC – This week, the Indiana Clinical and Translational Sciences Institute (CTSI) was awarded $33 million in grant funding from the National Institutes of Health (NIH). Congresswoman Susan W. Brooks (R-IN05) is an avid supporter of funding for NIH research programs and advocated for this funding in a letter sent to CTSI exactly one year ago today.
“The Indiana CTSI has forged significant partnerships and engaged in vital research since it was established in 2008.” said Brooks. “This additional funding will accelerate their work to combat the opioid crisis, obesity, infant mortality, chronic disease and health disparities. Indiana University, Purdue University and the University of Notre Dame have been leading research institutions of the Indiana CTSI and have collaborated with organizations including Indiana University Health, BioCrossroads, Eli Lilly & Co., Cook Industries and Roche Diagnostics. I am proud Indiana CTSI’s strong collaborations are receiving deserved recognition and support through this grant funding from the National Institutes of Health.”
Indiana ranks 38th in the country on the longest running annual assessment of the nation’s health. According to the 2017 United Health Foundation’s America’s Health Ranking report, Indiana faced higher infant mortality rates and cancer death rates than 40 other states in the country. The same report shows Indiana is facing higher rates for premature death, cardiovascular deaths and drug rates than the vast majority of the country.
This five-year grant will help CTSI support many research efforts and programs throughout Indiana in order to improve public health statewide.